In the past 20 years, findings from immunological and genetic studies have highlighted causal immunological circuits of psoriasis that converge on adaptive immune pathways involving interleukin (IL)-17 and IL-23 [1,22,23]. This evidence concerns the gene IL17A and psoriasis.